REGULATORY ASPECT OF PHARMACEUTICAL CHANGE CONTROL SYSTEM

  • Devesh Sharma Jaipur National University,Jagatpura,Jaipur
  • Vandana Sharma Maharishi Arvind Institute Of Pharmacy,Mansarovar,Jaipur
DOI https://doi.org/10.22270/jddt.v1i1.6

Abstract

The change control is “A process that ensures that changes to materials; methods, equipment and software are properly documented, validated, approved and traceableâ€. The process requires eight basic steps: Identification, documentation review, change proposal, change classification, implementation plan, installation, verification, closure. Changes are outlines as Major, Moderate & Minor. A compliance of regulatory group within the company determines the filing impact and submits it to FDA,-A prior- Approval supplement (PAS) for major changes, A CBE -30 or CBE-0 for moderate changes or Annual report for Minor changes. Firms are expected to write adequate SOP for the change control & be in total compliance with proper documentation. Considering the regulatory prospective of change control procedures, it is important to note that there are many guideline which describe the control of changes in manufacturing few references includes 21 CFR Part 211: Sec. 211.100, 21 CFR Part 211.194 (Laboratory Records), ICH Q7A and USFDA Guidance for Industry:  Change to an approved NDA or ANDA (April 2004- Revison-1).

Downloads

Download data is not yet available.

Author Biographies

Devesh Sharma, Jaipur National University,Jagatpura,Jaipur
M.Pharm in Drug Regulatory Affairs
Vandana Sharma, Maharishi Arvind Institute Of Pharmacy,Mansarovar,Jaipur
Lecturer
Statistics
550 Views | 300 Downloads
How to Cite
1.
Sharma D, Sharma V. REGULATORY ASPECT OF PHARMACEUTICAL CHANGE CONTROL SYSTEM. JDDT [Internet]. 25Oct.2011 [cited 23Jan.2021];1(1). Available from: http://jddtonline.info/index.php/jddt/article/view/6
Issue
Vol 1 No 1 (2011): Volume 1, Issue 1, Sept-Oct 2011
Section
Review

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).